KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Other financing activities (2016 - 2026)

Medtronic (MDT) has disclosed Other financing activities for 13 consecutive years, with -$5.0 million as the latest value for Q1 2026.

  • Quarterly Other financing activities fell 103.12% to -$5.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$220.0 million through Jan 2026, down 260.58% year-over-year, with the annual reading at -$184.0 million for FY2025, 6033.33% down from the prior year.
  • Other financing activities hit -$5.0 million in Q1 2026 for Medtronic, roughly flat from -$5.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $273.0 million in Q3 2022 to a low of -$719.0 million in Q1 2023.
  • Historically, Other financing activities has averaged -$19.2 million across 5 years, with a median of -$5.0 million in 2025.
  • Biggest five-year swings in Other financing activities: soared 6925.0% in 2022 and later tumbled 11883.33% in 2023.
  • Year by year, Other financing activities stood at $170.0 million in 2022, then decreased by 5.29% to $161.0 million in 2023, then crashed by 130.43% to -$49.0 million in 2024, then soared by 89.8% to -$5.0 million in 2025, then changed by 0.0% to -$5.0 million in 2026.
  • Business Quant data shows Other financing activities for MDT at -$5.0 million in Q1 2026, -$5.0 million in Q4 2025, and $70.0 million in Q3 2025.